The University of Chicago Header Logo

Connection

Everett E. Vokes to Anticarcinogenic Agents

Back to Details
This is a "connection" page, showing publications Everett E. Vokes has written about Anticarcinogenic Agents.
Everett E. Vokes
Connection Strength
0.068
Anticarcinogenic Agents
  1. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006 Apr 05; 98(7):441-50.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.